GlassScriptPhysician profile
Trisha Beth Weymers
NPI 1952911059
$16,499.00
in general payments reported to CMS, 2019-2025
24 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,470 · 2022: $9,164 · 2023: $5,601 · 2024: $128 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,458 · Food and Beverage: $296 · Debt Forgiveness: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,458.34 |
| Food and Beverage | $295.65 |
| Debt Forgiveness | $111.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14,406.10 | 2022-2024 | Auryon Laser System 100-120 Vac, Auryon Atherectomy Catheter 1.5 Mm Otw, Auryon Laser System 100-120 Vac |
| Amgen INC. | $283.12 | 2021 | |
| Astellas Pharma US INC | $282.11 | 2021-2022 | |
| Janssen Biotech, INC. | $197.83 | 2021-2022 | |
| Blue Earth Diagnostics | $157.80 | 2021-2024 | |
| Myovant Sciences INC. | $136.65 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $127.66 | 2021-2022 | |
| Urogen Pharma, INC. | $121.93 | 2021 | |
| Paratek Pharmaceuticals, INC. | $105.53 | 2023 | Nuzyra |
| Janssen Pharmaceuticals, INC | $99.74 | 2022 | |
| Smith+Nephew, INC. | $96.69 | 2025 | Collagenase Santyl, Regranex |
| W. L. Gore & Associates, INC. | $78.67 | 2021-2022 | |
| Tactile Systems Technology INC | $59.82 | 2022 | |
| Merck Sharp & Dohme LLC | $55.53 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $49.78 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $48.87 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $42.62 | 2021 | |
| Advanced Oxygen Therapy INC. | $38.80 | 2025 | Topical Oxygen Chamber For Extremities |
| Astrazeneca Pharmaceuticals LP | $31.22 | 2021 | |
| Boston Scientific Corporation | $20.21 | 2022 | |
| Medtronic, INC. | $18.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.03 | 2022 | |
| Urovant Sciences INC | $14.23 | 2021 | |
| Cardiovascular Systems INC. | $10.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trisha Weymers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.